Skip to main content
. 2016 May 21;18:111. doi: 10.1186/s13075-016-1018-x

Fig. 6.

Fig. 6

Prevalence of consensus criteria antiphospholipid antibodies (aPL) tested by line immunoassay (LIA), enzyme-linked immunosorbent assay (ELISA), and lupus anticoagulant (LA) analysis in 61 patients with antiphospholipid syndrome (APS), 24 aPL-positive (aPL+) individuals, and 23 Veneral Disease Laboratory test-positive (VDRL+) patients. aß2GPI antibeta2-glycoprotein I, aCL anticardiolipin, aPA antiphosphatidic acid, aPE antiphosphatidylethanolamine, aPG antiphosphatidylglycerol, aPI antiphosphatidylinositol, aPL+ asymptomatic carriers with autoantibodies to phospholipids, aPS antiphosphatidylserine. *P < 0.05; **p < 0.0001; §not done